Isolation of tryptic fragment of antigen from mitochondrial inner membrane proteins reacting with antimitochondrial antibody in sera of patients with primary biliary cirrhosis

Daisaku Muno, Eiki Kominami, Hideo Ishii, Koh Usui, Koji Saifuku, Yuji Sakakibara, Toshihiko Namihisa – 1 January 1990 – Most of the sera from patients with primary biliary cirrhosis contains antimitochondrial antibodies, which react with four proteins of the mitochondrial inner membrane. We reported in a previous paper that when beef heart mitochondrial inner membrane proteins were digested by trypsin, a new reactive 36 kDa fragment with antimitochondrial antibody was obtained.

Ito‐cell gene expression and collagen regulation

Francis R. Weiner, Marie‐Adele Giambrone, Mark J. Czaja, Anish Shah, Giorgio Annoni, Shizuko Takahashi, Mahboubeh Eghbali, Mark A. Zern – 1 January 1990 – Ito cells are perisinusoidal cells thought to be a major source of collagen in normal and fibrotic livers. These cells appear to have features similar to several cell types but when cultured assume a fibroblast‐like morphology. In this study we evaluated the phenotype of both freshly isolated and cultured Ito cells by examining their gene expression.

Fulminant hepatic failure caused by acute fatty liver of pregnancy treated by orthotopic liver transplantation

Samuel A. Ockner, Elizabeth M. Brunt, Steven M. Cohn, Elaine S. Krul, Douglas W. Hanto, Marion G. Peters – 1 January 1990 – A previously healthy 35‐year‐old woman was seen at 37 weeks' gestation with a 10‐day history of fever, vomiting, diarrhea and malaise. Serum laboratory findings included elevation of serum bilirubin and AST, prolongation of serum prothrombin time and a positive monospot. A tentative diagnosis of acute fatty liver of pregnancy was made, and a healthy male infant was delivered by emergency cesarean section because of fetal distress.

Elevation of facilitated glucose‐transporter messenger RNA in human hepatocellular carcinoma

Tsung‐Sheng Su, Ting‐Fen Tsai, Chin‐Wen Chi, Shou‐Hwa Han, Chen‐Kung Chou – 1 January 1990 – Complementary DNA of a rat brain glucose transporter gene was used to examine the expression of glucose‐transporter messenger RNA in paired human hepatocellular carcinomas and adjacent nontumorous liver tissues, as well as in human hepatoma cell lines and human fetal liver samples. High expression of a major 2.8‐kilobase glucose‐transporter transcript was seen in all hepatoma cell lines and fetal liver samples examined, whereas a much lower level of expression was observed in liver tissues.

Incorporation of iododeoxyuridine into neoplastic DNA: A fraudulent magic bullet?

Paul Calabresi, Gregory Curt – 1 January 1990 – Fourteen patients received 5‐iodo‐2 ‐deoxyuridine (IdUrd) before surgery for placement of a hepatic arterial catheter. Biopsy specimens were obtained at the time of surgery and the incorporation of IdUrd into DNA in tumor and normal hepatic tissue was measured by high‐performance liquid chromatography and used as an index of drug selectivity. Over a 3‐day intravenous infusion of IdUrd at 1,000 mg/m2/day, substitution for thymidine in tumor DNA averaged 3.1%. Normal hepatic DNA contained <1% substitution by IdUrd.

Tumor necrosis factor‐α induces a kB sequence‐specific DNA‐binding protein in human hepatoblastoma HepG2 cells

Ranjit Banerjee, Saul Karpen, Miriam Siekevitz, Gabriella Lengyel, Joachim Bauer, George Acs – 1 December 1989 – Tumor necrosis factor‐α is an inducer of acute‐phase protein synthesis in liver cells. The mechanism by which tumor necrosis factor‐α alters gene expression in these cells is largely unknown. In this study, we demonstrate that tumor necrosis factor‐α stimulates human immunodeficiency virus‐1 long terminal repeat‐promoted gene expression in the human hepatoblastoma HepG2 cell line and increased binding of trans‐activating factors to kappa B (kB) DNA sequences.

Pharmacokinetics of benzodiazepine antagonist Ro 15–1788 in cirrhotic patients with moderate or severe liver dysfunction

Gilles Pomier‐Layrargues, J.‐François Giguère, Joël Lavoie, Bernard Willems, Roger F. Butterworth – 1 December 1989 – Ro 15–1788, a benzodiazepine antagonist, has been advocated as a new treatment for hepatic encephalopathy. This drug is extensively metabolized by the liver in normal subjects. In the present study, we examined Ro 15–1788 disposition in eight healthy controls (Group I), eight cirrhotic patients with moderately impaired liver function (Pugh score >10, Group II) and eight patients with severe liver dysfunction (Pugh score > 10, Group III).

Interaction of hemopexin, albumin and liver fatty acid‐binding protein with protoporphyrin

Elizabeth Knobler, Maureen B. Poh‐Fitzpatrick, Donna Kravetz, William R. Vincent, Ursula Muller‐Eberhard, Styliani H. Vicent – 1 December 1989 – Equilibrium constants for the binding of protoporphyrin to serum albumin and hemopexin and liver cytosolic fatty acid‐binding protein of the rat were determined fluorometrically. The experimental equilibrium constant [106M−1 (mean ± S. D.)] values were 8.4 ± 1.3, 10.0 ± 2.4 and 34.0 ± 3.0 for albumin, hemopexin and liver fatty acid‐binding protein, respectively.

Subscribe to